UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015949
Receipt number R000018280
Scientific Title A Prospective, Multi-center Phase II Trial on the Efficacy and Safety of Low-dose Erlotinib Monotherapy for Frail Patients with EGFR Mutation-positive, Non-small Cell Lung Cancer(TORG1425)
Date of disclosure of the study information 2014/12/15
Last modified on 2020/05/15 14:48:14

No. Disposal Last modified on Item of update
1 Insert 2014/12/15 13:55:08
2 Update 2014/12/15 14:00:21 Email
3 Update 2014/12/17 10:50:38 Anticipated trial start date
4 Update 2016/05/19 13:27:45 Name of primary person or sponsor
Organization
Organization
Organization
5 Update 2016/05/19 13:30:18 Organization
Organization
6 Update 2016/05/19 13:32:20 Organization
7 Update 2017/12/11 09:25:55 Recruitment status
8 Update 2018/06/19 09:17:35 Last follow-up date
9 Update 2019/04/24 09:30:22 Recruitment status
Date of IRB
Anticipated trial start date
10 Update 2020/05/15 14:43:09 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
11 Update 2020/05/15 14:48:14 URL related to results and publications